Literature DB >> 26775689

Regulated necrosis: disease relevance and therapeutic opportunities.

Marcus Conrad1, José Pedro Friedmann Angeli1, Peter Vandenabeele2,3,4, Brent R Stockwell5.   

Abstract

The discovery of regulated cell death presents tantalizing possibilities for gaining control over the life-death decisions made by cells in disease. Although apoptosis has been the focus of drug discovery for many years, recent research has identified regulatory mechanisms and signalling pathways for previously unrecognized, regulated necrotic cell death routines. Distinct critical nodes have been characterized for some of these alternative cell death routines, whereas other cell death routines are just beginning to be unravelled. In this Review, we describe forms of regulated necrotic cell death, including necroptosis, the emerging cell death modality of ferroptosis (and the related oxytosis) and the less well comprehended parthanatos and cyclophilin D-mediated necrosis. We focus on small molecules, proteins and pathways that can induce and inhibit these non-apoptotic forms of cell death, and discuss strategies for translating this understanding into new therapeutics for certain disease contexts.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26775689      PMCID: PMC6531857          DOI: 10.1038/nrd.2015.6

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  193 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain.

Authors:  Si-Eun Yoo; Liuji Chen; Ren Na; Yuhong Liu; Carmen Rios; Holly Van Remmen; Arlan Richardson; Qitao Ran
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

3.  Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.

Authors:  L H Zhang; H D Youn; J O Liu
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

4.  Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death.

Authors:  Shaida A Andrabi; Ho Chul Kang; Jean-François Haince; Yun-Il Lee; Jian Zhang; Zhikai Chi; Andrew B West; Raymond C Koehler; Guy G Poirier; Ted M Dawson; Valina L Dawson
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

5.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

6.  Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos).

Authors:  Yingfei Wang; No Soo Kim; Jean-Francois Haince; Ho Chul Kang; Karen K David; Shaida A Andrabi; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Sci Signal       Date:  2011-04-05       Impact factor: 8.192

7.  Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

Authors:  Kim Newton; Debra L Dugger; Katherine E Wickliffe; Neeraj Kapoor; M Cristina de Almagro; Domagoj Vucic; Laszlo Komuves; Ronald E Ferrando; Dorothy M French; Joshua Webster; Merone Roose-Girma; Søren Warming; Vishva M Dixit
Journal:  Science       Date:  2014-02-20       Impact factor: 47.728

8.  Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis.

Authors:  S M Laster; J G Wood; L R Gooding
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

9.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

View more
  196 in total

Review 1.  The Brain after Cardiac Arrest.

Authors:  Jonathan Elmer; Clifton W Callaway
Journal:  Semin Neurol       Date:  2017-02-01       Impact factor: 3.420

2.  Broken hearts: Iron overload, ferroptosis and cardiomyopathy.

Authors:  Marcus Conrad; Bettina Proneth
Journal:  Cell Res       Date:  2019-04       Impact factor: 25.617

Review 3.  Repairing plasma membrane damage in regulated necrotic cell death.

Authors:  Rafael A Espiritu
Journal:  Mol Biol Rep       Date:  2021-03-09       Impact factor: 2.316

4.  Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition.

Authors:  Hugo Brito; Vanda Marques; Marta B Afonso; Dean G Brown; Ulf Börjesson; Nidhal Selmi; David M Smith; Ieuan O Roberts; Martina Fitzek; Natália Aniceto; Rita C Guedes; Rui Moreira; Cecília M P Rodrigues
Journal:  Cell Death Discov       Date:  2020-02-11

5.  Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation.

Authors:  Massimo Bonora; Claudia Morganti; Giampaolo Morciano; Gaia Pedriali; Magdalena Lebiedzinska-Arciszewska; Giorgio Aquila; Carlotta Giorgi; Paola Rizzo; Gianluca Campo; Roberto Ferrari; Guido Kroemer; Mariusz R Wieckowski; Lorenzo Galluzzi; Paolo Pinton
Journal:  EMBO Rep       Date:  2017-05-31       Impact factor: 8.807

6.  Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis.

Authors:  Xiaofang Sun; Xiaohua Niu; Ruochan Chen; Wenyin He; De Chen; Rui Kang; Daolin Tang
Journal:  Hepatology       Date:  2016-05-24       Impact factor: 17.425

Review 7.  Small molecule probes for cellular death machines.

Authors:  Ying Li; Lihui Qian; Junying Yuan
Journal:  Curr Opin Chem Biol       Date:  2017-06-16       Impact factor: 8.822

8.  Gentamicin-Induced Acute Kidney Injury in an Animal Model Involves Programmed Necrosis of the Collecting Duct.

Authors:  Huihui Huang; William W Jin; Ming Huang; Heyu Ji; Diane E Capen; Yin Xia; Junying Yuan; Teodor G Păunescu; Hua A Jenny Lu
Journal:  J Am Soc Nephrol       Date:  2020-07-08       Impact factor: 10.121

9.  ΔNp63 Inhibits Oxidative Stress-Induced Cell Death, Including Ferroptosis, and Cooperates with the BCL-2 Family to Promote Clonogenic Survival.

Authors:  Gary X Wang; Ho-Chou Tu; Yiyu Dong; Anders Jacobsen Skanderup; Yufeng Wang; Shugaku Takeda; Yogesh Tengarai Ganesan; Song Han; Han Liu; James J Hsieh; Emily H Cheng
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

10.  Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.

Authors:  Yi-Yue Zhang; Wei-Ning Liu; Yue-Qi Li; Xiao-Jie Zhang; Jie Yang; Xiu-Ju Luo; Jun Peng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.